TNF and rheumatoid arthritis: Given tacrolimus’s inhibitory effects on the expression of pro-inflammatory cytokines such as IL-17A and tumor necrosis factor-α (TNF-α), primarily through the modulation of Th17 cell activity,11 and its established role in managing active RA,12 it was hypothesized that tacrolimus could similarly reduce inflammation in AS.